Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microscopy, Rapid Diagnostic Tests), By End Use (Clinics, Hospitals), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
Lung Cancer Screening Software Market Growth & Trends
The global lung cancer screening software market size is expected to reach USD 45.0 million by 2030, registering a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.
A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.
Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.
Lung Cancer Screening Software Market Report Highlights
Lung Cancer Screening Software Market Growth & Trends
The global lung cancer screening software market size is expected to reach USD 45.0 million by 2030, registering a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.
A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.
Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.
Lung Cancer Screening Software Market Report Highlights
- In 2023, North America accounted for the highest revenue share owing to various lung cancer screening programs and favorable reimbursement scenario in the region
- Asia Pacific is expected to be the fastest-growing regional market over the forecast period
- This is attributed to the increasing cases of lung cancer and rise in the number of screening trials & studies for the disease
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MALARIA DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
3.2.1.2. Development of technologically advanced and efficient diagnostics
3.2.1.3. Market players and private investors to curb the prevalence of malaria
3.2.2. Market restraint analysis
3.2.2.1. Increasing number of countries in the malaria elimination phase
3.2.2.2. Demand for low-cost malaria diagnostic tests
3.3. Malaria Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. MALARIA DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Malaria Diagnostics Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Molecular Diagnostic Tests
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Conventional PCR
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Modernized PCR
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Microscopy
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Diagnostic Tests (RDT)
CHAPTER 5. MALARIA DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Method Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Malaria Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals & Clinics
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Diagnostic Centers
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Academic and Research Institutes
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. MALARIA DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. Africa
6.5.1. Nigeria
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Democratic Republic of the Congo
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. United Republic of Tanzania
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Uganda
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. South Africa
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Mozambique
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Angola
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Ghana
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
6.5.9. Botswana
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
6.5.10. Namibia
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework/ reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
6.6. South East Asia
6.6.1. India
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Myanmar
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Indonesia
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Eastern Mediterranean
6.7.1. Saudi Arabia
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Pakistan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Western Pacific
6.8.1. China
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Papua New Guinea
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Cambodia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Americas
6.9.1. Venezuela
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Brazil
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. Colombia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Europe
6.10.1. UK
6.10.1.1. Key country dynamics
6.10.1.2. Regulatory framework/ reimbursement structure
6.10.1.3. Competitive scenario
6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.10.2. Germany
6.10.2.1. Key country dynamics
6.10.2.2. Regulatory framework/ reimbursement structure
6.10.2.3. Competitive scenario
6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.10.3. France
6.10.3.1. Key country dynamics
6.10.3.2. Regulatory framework/ reimbursement structure
6.10.3.3. Competitive scenario
6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.10.4. Turkey
6.10.4.1. Key country dynamics
6.10.4.2. Regulatory framework/ reimbursement structure
6.10.4.3. Competitive scenario
6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Access Bio, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott Laboratories
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Premier Medical Corporation Pvt. Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Sysmex Partec GmbH
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens Healthineers
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. bioMйrieux
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Beckman Coulter, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Leica Microsystems GmbH
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Bio-Rad Laboratories, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Technology
1.2.2. End Use
1.2.3. Regional scope
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Technology outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
CHAPTER 3. MALARIA DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
3.2.1.2. Development of technologically advanced and efficient diagnostics
3.2.1.3. Market players and private investors to curb the prevalence of malaria
3.2.2. Market restraint analysis
3.2.2.1. Increasing number of countries in the malaria elimination phase
3.2.2.2. Demand for low-cost malaria diagnostic tests
3.3. Malaria Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
CHAPTER 4. MALARIA DIAGNOSTICS MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
4.1. Technology Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Malaria Diagnostics Market by Technology Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4.1. Molecular Diagnostic Tests
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.2. Conventional PCR
4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.1.3. Modernized PCR
4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Microscopy
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.3. Rapid Diagnostic Tests (RDT)
CHAPTER 5. MALARIA DIAGNOSTICS MARKET: END USE ESTIMATES & TREND ANALYSIS
5.1. Method Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Malaria Diagnostics Market by End Use Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4.1. Hospitals & Clinics
5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
5.4.2. Diagnostic Centers
5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.4.3. Academic and Research Institutes
5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 6. MALARIA DIAGNOSTICS MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. Africa
6.5.1. Nigeria
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
6.5.2. Democratic Republic of the Congo
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
6.5.3. United Republic of Tanzania
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
6.5.4. Uganda
6.5.4.1. Key country dynamics
6.5.4.2. Regulatory framework/ reimbursement structure
6.5.4.3. Competitive scenario
6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
6.5.5. South Africa
6.5.5.1. Key country dynamics
6.5.5.2. Regulatory framework/ reimbursement structure
6.5.5.3. Competitive scenario
6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
6.5.6. Mozambique
6.5.6.1. Key country dynamics
6.5.6.2. Regulatory framework/ reimbursement structure
6.5.6.3. Competitive scenario
6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
6.5.7. Angola
6.5.7.1. Key country dynamics
6.5.7.2. Regulatory framework/ reimbursement structure
6.5.7.3. Competitive scenario
6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
6.5.8. Ghana
6.5.8.1. Key country dynamics
6.5.8.2. Regulatory framework/ reimbursement structure
6.5.8.3. Competitive scenario
6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
6.5.9. Botswana
6.5.9.1. Key country dynamics
6.5.9.2. Regulatory framework/ reimbursement structure
6.5.9.3. Competitive scenario
6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
6.5.10. Namibia
6.5.10.1. Key country dynamics
6.5.10.2. Regulatory framework/ reimbursement structure
6.5.10.3. Competitive scenario
6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
6.6. South East Asia
6.6.1. India
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
6.6.2. Myanmar
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
6.6.3. Indonesia
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
6.7. Eastern Mediterranean
6.7.1. Saudi Arabia
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
6.7.2. Pakistan
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
6.8. Western Pacific
6.8.1. China
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
6.8.2. Papua New Guinea
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
6.8.3. Cambodia
6.8.3.1. Key country dynamics
6.8.3.2. Regulatory framework/ reimbursement structure
6.8.3.3. Competitive scenario
6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
6.9. Americas
6.9.1. Venezuela
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
6.9.2. Brazil
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
6.9.3. Colombia
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
6.10. Europe
6.10.1. UK
6.10.1.1. Key country dynamics
6.10.1.2. Regulatory framework/ reimbursement structure
6.10.1.3. Competitive scenario
6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
6.10.2. Germany
6.10.2.1. Key country dynamics
6.10.2.2. Regulatory framework/ reimbursement structure
6.10.2.3. Competitive scenario
6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
6.10.3. France
6.10.3.1. Key country dynamics
6.10.3.2. Regulatory framework/ reimbursement structure
6.10.3.3. Competitive scenario
6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
6.10.4. Turkey
6.10.4.1. Key country dynamics
6.10.4.2. Regulatory framework/ reimbursement structure
6.10.4.3. Competitive scenario
6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 7. COMPETITIVE LANDSCAPE
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Access Bio, Inc.
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Abbott Laboratories
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Premier Medical Corporation Pvt. Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Sysmex Partec GmbH
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Siemens Healthineers
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. bioMйrieux
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Beckman Coulter, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Leica Microsystems GmbH
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Bio-Rad Laboratories, Inc.
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
